Updated · American Association for Cancer Research (AACR) · Jul 7
NCI Study Finds Men Face Later-Stage Diagnosis in 20 Cancer Types Across 2.4 Million Cases
Updated
Updated · American Association for Cancer Research (AACR) · Jul 7
NCI Study Finds Men Face Later-Stage Diagnosis in 20 Cancer Types Across 2.4 Million Cases
3 articles · Updated · American Association for Cancer Research (AACR) · Jul 7
Summary
A 2.4 million-case NCI analysis found U.S. men were more likely than women to be diagnosed at a later stage in 20 nonreproductive cancers between 2015 and 2022.
The study links that pattern to a possible explanation for higher male cancer mortality, with NCI estimates showing 171.5 deaths per 100,000 diagnosed men versus 126.3 for women.
Men showed the biggest excess odds for advanced disease in tongue, thyroid, salivary gland, stomach and oropharyngeal cancers, including 151% higher odds of regional tongue cancer and 134% higher odds of distant tongue cancer.
Similar patterns held across racial, ethnic and county-income groups, though men were less likely than women to present late in a few cancers including bladder, anal, liver and laryngeal disease.
Researchers said screening uptake, healthcare-seeking behavior and possible differences in clinical response to symptoms may drive the gap, while noting limits including missing insurance data and over 10% missing staging data for some cancers.
What explains why men are diagnosed later for thyroid cancer but earlier for bladder cancer than women?
If early cancer detection is vital, why is widespread screening not recommended for the most common male cancer?
Beyond awareness campaigns, what systemic changes can overcome men’s historic reluctance to seek medical care?
The Hidden Crisis: Why Men Consistently Receive Later-Stage Cancer Diagnoses Across All Demographics
Overview
A recent study led by Beth Maclin and her team reveals a significant and consistent disparity in cancer diagnosis: men are more likely than women to be diagnosed at a later stage, when cancer has already progressed. This pattern holds true across different races, ethnicities, and income levels, showing that the male disadvantage is not just about access to healthcare or social factors. Instead, the forces behind this issue are deeply rooted and widespread, suggesting that broader biological or behavioral mechanisms are at play. These findings highlight the urgent need for targeted strategies to improve early cancer detection in men.